Mass Torts Litigation in California: Don’t Forget the Science

pharmaceutical mass tort

Without a way to consolidate cases outside of plaintiff-friendly California, the defense bar will now have one less option in battling these claims. Importantly, and especially with product liability mass torts, the science will become more central to these claims as the parties will engage in a “battle of the experts” subject to the Kelly/Frye admissibility threshold (which some argue has become more Daubert-like after Sargon). Indeed, expert admissibility could become the next “dispositive” blow the defense will use to quash these claims. For plaintiffs and defendants alike, the general causation question will be even more critical to success.